Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-027735
Filing Date
2025-02-26
Accepted
2025-02-26 16:10:35
Documents
130
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnkd-20241231.htm   iXBRL 10-K 4744186
2 EX-19.1 mnkd-ex19_1.htm EX-19.1 43242
3 EX-23.1 mnkd-ex23_1.htm EX-23.1 3408
4 EX-31.1 mnkd-ex31_1.htm EX-31.1 11885
5 EX-31.2 mnkd-ex31_2.htm EX-31.2 11884
6 EX-32.1 mnkd-ex32_1.htm EX-32.1 7848
7 EX-32.2 mnkd-ex32_2.htm EX-32.2 7860
8 GRAPHIC img31013618_0.jpg GRAPHIC 229386
  Complete submission text file 0000950170-25-027735.txt   22260915

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20241231.xsd EX-101.SCH 3066316
133 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20241231_htm.xml XML 4455720
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50865 | Film No.: 25670116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)